Quetiapine (Qrono)

喹硫平 (Qrono)

Report date: 2023/10/20 10:03:48

Base Information

Drug NameQuetiapine (Qrono)
Drug Alias NameQR-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 antagonistsSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists +[5] 
TargetsAdrenergic receptorsAdrenergic receptors alpha-2Serotonin 1a (5-HT1a) receptor +[5] 
Therapy Area/IndicationsMental DisordersRenal Insufficiency, ChronicSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQrono Inc
China Registration ClassN/A

Develop Information

Active CompaniesFlinders UniversityAssiut UniversityQrono Inc
Inactive CompaniesN/A
Active IndicationsMental DisordersRenal Insufficiency, ChronicSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A